RxDoctor Payments Data

Savina Aneja

Dermatology · Orlando, FLNPI 1184985996

Payments from drug & device makers

$17,525in general payments, 2019–2025

Across 483 payments — averaging $36.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$8K
  • Novartis$2K
  • AbbVie$2K
  • Lilly USA, LLC$697
  • Johnson & Johnson$531
  • Sanofi$496
  • plus $4K from 31 others
$1,829in research payments, 2019–2025

Across 1 payment — averaging $1829.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2K

What the payments were for

  • Consulting fees$7,19041%
  • Travel & lodging$7684%
  • Food & beverage$9,42154%
  • Education$1471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,525 in reported general payments places this provider in the 80th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$131,386
Medicare patients
369
Services billed
2,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab21$79,766
Dupixent SyringeDupilumab13$50,925
Clobetasol Propionate145$5,431
Ketoconazole147$2,468
Tretinoin30$1,948
Triamcinolone Acetonide165$1,889
Metronidazole39$1,395
Dutasteride24$1,309
Clindamycin Phosphate53$1,133
Fluocinonide24$1,092
Doxycycline Hyclate37$531
Hydrocortisone85$458
Minoxidil40$391
Ciclopirox12$379
CiclopiroxCiclopirox Olamine17$354

Paid to pharmacies, not to this prescriber.

Other dermatology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →